Relmada Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 13/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 13/11/2025 | Jun 2024Filed 13/11/2025 | Mar 2024Filed 13/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$13 | −$19 | −$10 | −$9.9 | −$18 | −$22 | −$18 | −$22 | |
| −$0.11 | −$0.22 | −$0.30 | −$0.30 | −$0.58 | −$0.72 | −$0.59 | −$0.72 | |
| 112 | 87 | 33 | 33 | 30 | 30 | 30 | 30 |
Trend